AI assistant
Sending…
BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2013
Jul 24, 2013
31868_dirs_2013-07-24_2f070a92-3509-4c8e-960b-cf34c6df2977.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2013-07-22
Reporting Person: Cohen Fred E (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option | $4.27 | 2022-09-21 | Common Stock (54250) | Direct | |
| Non-Qualified Stock Option | $1.29 | 2023-03-19 | Common Stock (100000) | Direct |
More from BIOCRYST PHARMACEUTICALS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 24
Regulatory Filings
2026
Mar 20